Rhodotorula minuta as onychomycosis agent in a Chinese patient: First report and literature review

Mycoses

Volumn 57, Issue 3, 2014, Pages 191-195

  Zhou, Jie ^a   Chen, Min ^a   Chen, Hongduo ^b   Pan, Weihua ^a   Liao, Wanqing ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

ITS; Onychomycosis; PSO; Rhodotorula; Rhodotorula minuta

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; VORICONAZOLE;

ADOLESCENT; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CASE REPORT; CHINESE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NAIL INFECTION; NUCLEOTIDE SEQUENCE; ONYCHOMYCOSIS; PRIORITY JOURNAL; RHODOTORULA; RHODOTORULA MINUTA;

ARTHRODERMATACEAE; RHODOTORULA MINUTA;

ITS; ONYCHOMYCOSIS; PSO; RHODOTORULA; RHODOTORULA MINUTA;

ADOLESCENT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DRUG RESISTANCE, FUNGAL; FEMALE; FLUCONAZOLE; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; ONYCHOMYCOSIS; PYRIMIDINES; RHODOTORULA; TRIAZOLES;

EID: 84893778634     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12143     Document Type: Article

References (36)

1. Gupta AK. Types of onychomycosis. Cutis 2001; 68: 4-7.
2. Elewski BE, Charif MA. Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions. Arch Dermatol 1997; 133: 1172-3.
3. Elewski BE. Onychomycosis: pathogenesis, diagnosis, and management. Clin Microbiol Rev 1998; 11: 415-29.
4. Faergemann J, Correia O, Nowicki R, Ro BI. Genetic predisposition-understanding underlying mechanisms of onychomycosis. J Eur Acad Dermatol Venereol 2005; 19: 17-9.
5. Murray SC, Dawber RP. Onychomycosis of toenails: orthopaedic and podiatric considerations. Australas J Dermatol 2002; 43: 105-12.
6. Achten G, Wanet-Rouard J. Onychomycoses in the laboratory. Mykosen Suppl 1978; 1: 125-7.
7. Liao Wanqing WS, Gao Z. Mycosis. Beijing, China: People's Medical Publishing House. 2003: pp. 208-9.
8. Jayatilake JA, Tilakaratne WM, Panagoda GJ. Candidal onychomycosis: a mini-review. Mycopathologia 2009; 168: 165-73.
9. Vartivarian SE, Anaissie EJ, Bodey GP. Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management. Clin Infect Dis 1993; 17: S487-91.
10. Means AD, Sisto K, Lichon V, Monaghan D, O'Keefe P, Tung R. Cutaneous Rhodotorula treated with photodynamic therapy. Dermatol Surg 2012; 38: 1100-3.
11. da Cunha MM, dos Santos LP, Dornelas-Ribeiro M, Vermelho AB, Rozental S. Identification, antifungal susceptibility and scanning electron microscopy of a keratinolytic strain of Rhodotorula mucilaginosa: a primary causative agent of onychomycosis. FEMS Immunol Med Microbiol 2009; 55: 396-403.
12. Liu Gang WY, Zhou Y. Distribution of Rhodotorula in fish. Acta Sci Nat Univ Nankaiensis 1999; 32: 124-5.
13. Fell JW, Boekhout T, Fonseca A, Scorzetti G, Statzell-Tallman A. Biodiversity and systematics of basidiomycetous yeasts as determined by large-subunit rDNA D1/D2 domain sequence analysis. Int J Syst Evol Microbiol 2000; 50: 1351-71.
14. Tuon FF, Costa SF. Rhodotorula infection. A systematic review of 128 cases from literature. Rev Iberoam Micol 2008; 25: 135-40.
15. Pfaller MA, Diekema DJ, Gibbs DL et al. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 2007; 45: 1735-45.
16. Krcmery V, Krupova I, Denning DW. Invasive yeast infections other than Candida spp. in acute leukaemia. J Hosp Infect 1999; 41: 181-94.
17. Tuon FF, de Almeida GM, Costa SF. Central venous catheter-associated fungemia due to Rhodotorula spp. -a systematic review. Med Mycol 2007; 45: 441-7.
18. Thanos L, Mylona S, Kokkinaki A et al. Multifocal skeletal tuberculosis with Rhodotorula minuta co-infection. Scand J Infect Dis 2006; 38: 309-11.
19. Cutrona AF, Shah M, Himes MS, Miladore MA. Rhodotorula minuta: an unusual fungal infection in hip-joint prosthesis. Am J Orthop 2002; 31: 137-40.
20. Goldani LZ, Craven DE, Sugar AM. Central venous catheter infection with Rhodotorula minuta in a patient with AIDS taking suppressive doses of fluconazole. J Med Vet Mycol 1995; 33: 267-70.
21. Leibovitz E, Rigaud M, Chandwani S et al. Disseminated fungal infections in children infected with human immunodeficiency virus. Pediatr Infect Dis J 1991; 10: 888-94.
22. Pinna A, Carta F, Zanetti S, Sanna S, Sechi LA. Endogenous Rhodotorula minuta and Candida albicans endophthalmitis in an injecting drug user. Br J Ophthalmol 2001; 85: 759.
23. Nilgun C, Cihangir T, Lutfiye M. Rhodotorula minuta: uncommon yeast isolated as the causative agent of a right hip joint infection. J Mycol Med 2005; 15: 52-5.
24. Gregory JK, Haller JA. Chronic postoperative Rhodotorula endophthalmitis. Arch Ophthalmol 1992; 110: 1686-7.
25. Lee SH, Chiang SS, Hseih SJ et al. Successful treatment of fungal peritonitis with intracatheter antifungal retention. Adv Perit Dial 1995; 11: 172-5.
26. Kiehn TE, Gorey E, Brown AE et al. Sepsis due to Rhodotorula related to use of indwelling central venous catheters. Clin Infect Dis 1992; 14: 841-6.
27. Gupta AK, Ryder JE, Summerbell RC. Onychomycosis: classification and diagnosis. J Drugs Dermatol 2004; 3: 51-6.
28. Gupta AK, Ricci MJ. Diagnosing onychomycosis. Dermatol Clin 2006; 24: 365-9.
29. Scherer WP, Kinmon K. Dermatophyte test medium culture versus mycology laboratory analysis for suspected onychomycosis. A study of 100 cases in a geriatric population. J Am Podiatr Med Assoc 2000; 90: 450-9.
30. Gupta AK, Drummond-Main C, Cooper EA, Brintnell W, Piraccini BM, Tosti A. Systematic review of nondermatophyte mold onychomycosis: diagnosis, clinical types, epidemiology, and treatment. J Am Acad Dermatol 2012; 66: 494-502.
31. Kaur R, Kashyap B, Bhalla P. Onychomycosis-epidemiology, diagnosis and management. Indian J Med Microbiol 2008; 26: 108-16.
32. Anatoliotaki M, Mantadakis E, Galanakis E, Samonis G. Rhodotorula species fungemia: a threat to the immunocompromised host. Clin Lab 2003; 49: 49-55.
33. Marinova I, Szabadosova V, Brandeburova O, Krcmery VJr. Rhodotorula spp. fungemia in an immunocompromised boy after neurosurgery successfully treated with miconazole and 5-flucytosine: case report and review of the literature. Chemotherapy 1994; 40: 287-9.
34. Krzysciak P, Macura AB. Drug susceptibility of 64 strains of Rhodotorula sp. Wiad Parazytol 2010; 56: 167-70.
35. Zaas AK, Boyce M, Schell W et al. Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates. J Clin Microbiol 2003; 41: 5233-5.
36. Gomez-Lopez A, Mellado E, Rodriguez-Tudela JL, Cuenca-Estrella M. Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review. J Antimicrob Chemother 2005; 55: 312-6.